Status:
COMPLETED
Plasma Biomarkers of Cardiopulmonary Bypass Induced Acute Respiratory Distress Syndrome (CPB-ARDS)
Lead Sponsor:
Huazhong University of Science and Technology
Collaborating Sponsors:
Wuhan Asia Heart Hospital
Conditions:
Acute Respiratory Distress Syndrome
Eligibility:
All Genders
18+ years
Brief Summary
The investigators aimed to establish a prospective cohort of patients undergoing cardiopulmonary bypass (CPB) in cardiac surgery from April 2021 to September 2022, in Wuhan. The ARDS events, ventilati...
Eligibility Criteria
Inclusion
- Selective operation;
- Cardiac surgery with cardiopulmonary bypass;
- Adult patients over 18 years old;
- Signed informed consent
Exclusion
- patients who refuse to sign the informed consent form or the attending physician refuses the patient to join the study;
- non elective surgery (surgery at non-elective time or emergency surgery);
- preoperative pulmonary insufficiency, pulmonary hypertension and pulmonary inflammation;
- the absence of any specimen and clinical data;
- patients who failed the operation, needed extracorporeal membrane oxygenation support or underwent CPB operation again within 3 days after operation;
Key Trial Info
Start Date :
April 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 30 2022
Estimated Enrollment :
525 Patients enrolled
Trial Details
Trial ID
NCT04696172
Start Date
April 1 2021
End Date
August 30 2022
Last Update
December 13 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China, 430022
2
Wuhan Asia Heart Hospital
Wuhan, Hubei, China, 430022